The uroprotection of mesna on cyclophosphamide cystitis in rats. Its consequences on behaviour and brain activities;L'action uroprotectrice du mesna sur la cystite au cyclophosphamide chez le rat. Ses consequences sur le comportement et l'activite nerveuse

Comptes Rendus de l'Academie des Sciences - Serie III

Volumn 322, Issue 6, 1999, Pages 505-515

  Menétrey, Daniel ^a   Karine, Bon ^a   Michiels, Jean François ^b   Lantéri Minet, Michel ^a,c  

^a INSERM   (France)

^b UNIVERSITY HOSPITAL OF NICE   (France)

^c PASTEUR HOSPITAL   (France)

Author keywords

Bladder; Nervous system; Spinal cord; Vagal nerve; Visceronociception

Indexed keywords

CYCLOPHOSPHAMIDE; MESNA; ONCOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR; BRAIN STEM; CONTROLLED STUDY; CYSTITIS; DRUG INDUCED DISEASE; HISTOPATHOLOGY; INFLAMMATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NERVOUS SYSTEM; NONHUMAN; RAT; SENSORY NERVE; SPINAL CORD; VAGUS NERVE;

ANIMALIA;

EID: 0033149978     PISSN: 07644469     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0764-4469(99)80101-2     Document Type: Article

References (44)

1. Lantéri-Minet M., Bon K., Pommery De J., Michiels J.F., Menétrey D., Cyclophosphamide cystitis as a model of visceral pain in rats: Model elaboration and spinal structures involved as revealed by the expression of c-Fos and Krox-24 proteins, Exp. Brain Res. 105 (1995) 220-232.
2. Bon K., Lantéri-Minet M., Menétrey D., Berkley K.J., Sex, time-of-day and estrous variations in behavioral and bladder histological consequences of cyclophosphamide-induced cystitis in rats, Pain 73 (1997) 423-429.
3. Watson N.A., Notley R.G., Urological complications of cyclophosphamide, Br. J. Urol. 45 (1973) 606-609.
4. Brock N., Gross R., Hohorst H.J., Klein H.O., Schneider B., Activation of cyclophosphamide in man and animals, Cancer 27 (1971) 1512-1529.
5. Cox P.J., Cyclophosphamide cystitis - Identification of acrolein as the causative agent, Biochem. Pharmacol. 28 (1979) 2045-2049.
6. Bon K., Lantéri-Minet M., Pommery De J., Michiels J.F., Menétrey D., Cyclophosphamide cystitis as a model of visceral pain in rats: A survey of hindbrain structures involved in visceroception and nociception using the expression of c-fos and Krox-24 proteins, Exp. Brain Res. 108 (1996) 404-416.
7. Bon K., Lantéri-Minet M., Menétrey D., Involvement of the dorsal paratrigeminal nucleus in visceral pain-related phenomena, C.R. Acad. Sci./life Sci. (Paris) 320 (1997) 607-613.
8. Bon K., Lantéri-Minet M., Michiels J.F., Menétrey D., Cyclophosphamide cystitis as a model of visceral pain in rats: A c-fos and Krox-24 study at telencephalic levels, with a note on Pituitary Adenylate Cyclase Activating Polypeptide (PACAP), Exp. Brain Res. 122 (1998) 165-174.
9. Bon K., Lantéri-Minet M., Pommery De J., Michiels J.F., Menétrey D., Cyclophosphamide cystitis as a model of visceral pain in rats: Minor effects at mesodiencephalic levels as revealed by the expression of c-fos with a note on Krox-24, Exp. Brain Res. 113 (1997) 249-264.
10. Brock N., The development of mesna for the inhibition of urotoxic side effects of cyclophosphamide, ifosfamide, and other oxazaphosphorine cytostatics, Rec. Adv. Cancer Res. 74 (1980) 270-278.
11. Brock N., Pohl J., Stekar J., Studies on the urotoxicity of oxazaphosphorine cytostatics and its prevention. I. Experimental studies on the urotoxicity of alkylating compounds, Eur. J. Cancer 17 (1981) 595-607.
12. Brock N., Pohl J., Stekar J., Studies on the urotoxicity of oxazaphosphorine cytostatics and its prevention. II. Comparative study on the uroprotective efficacy of thiols and other sulfur compounds, Eur. J. Cancer Clin. Oncol. 17 (1981) 1155-1163.
13. Brock N., Pohl J., Stekar J., Scheef W., Studies on the urotoxicity of oxazaphosphorine cytostatics and its prevention. III. Profile of action of sodium 2-mercaptoethane sulfonate (mesna), Eur. J. Cancer Clin. Oncol. 18 (1982) 1377-1387.
14. Naquet R., Ethical and moral considerations in the design of experiments, Neuroscience 57 (1993) 183-189.
15. Tarapacki J.A., Kristal M.B., An adaptable microcomputer program for recording behavior durations, Physiol. Behav. 47 (1990) 381-384.
16. Hunt S.P., Pini A., Evan G., Induction of c-fos-like protein in spinal cord neurons following sensory stimulation, Nature 328 (1987) 632-634.
17. Menétrey D., Pommery De J., Baimbridge K.G., Thomasset M., Calbindin-D28k (CaBP28k)-like immunoreactivity in ascending projections. I. Trigeminal nucleus caudalis and dorsal vagal complex projections, Eur. J. Neurosci. 4 (1992) 61-69.
18. Philips F.S., Sternberg S.S., Cronin A.P., Vidal P.M., Cyclophosphamide and urinary bladder toxicity, Cancer Res. 21 (1961) 1577-1589.
19. Guyenet P.G., Koshiya N., Huangfu D., Baraban S.C., Stornetta R.L., Li Y.W., Role of medulla oblongata in generation of sympathetic and vagal outflows, in: Holstege G., Bandler R., Saper C.B. (Eds.), The Emotional Motor System, Prog. Brain Res. 107 (1996) 127-144.
20. Lu J., Hathaway C.B., Bereiter D.A., Adrenalectomy enhances foslike immunoreactivity within the spinal trigeminal nucleus induced by noxious thermal stimulation of the cornea, Neuroscience 54 (1993) 809-818.
21. Marfurt C.F., DelToro D.R., Corneal sensory pathway in the rat: A horseradish peroxidase tracing study, J. Comp. Neurol. 261 (1987) 450-459.
22. Martinez S., Belmonte C., c-Fos expression in trigeminal nucleus neurons after chemical irritation of the cornea: Reduction by selective blockade of nociceptor chemosensitivity, Exp. Brain Res. 109 (1996) 56-62.
23. McEchron M.D., McCabe P.M., Green E.J., Hitchcock J.M., SchneiDerman N., Immunohistochemical expression of the c-Fos protein in the spinal trigeminal nucleus following presentation of the corneal airpuff stimulus, Brain Res. 710 (1996) 112-120.
24. Meng I.D., Bereiter D.A., Differential distribution of fos-like immunoreactivity in the spinal trigeminal nucleus after noxious and innocuous thermal and chemical stimulation of rat cornea, Neuroscience 72 (1996) 243-254.
25. Nagano S., Myers J.A., Hall R.D., Representation of the cornea in the brain stem of the rat, Exp. Neurol. 49 (1975) 653-670.
26. Pozo M.A., Cervero F., Neurons in the rat spinal trigeminal complex driven by corneal nociceptors: Receptive-field properties and effects of noxious stimulation of the cornea, J. Neurophysiol. 70 (1993) 2370-2378.
27. Strassman A.M., Vos B.V., Somatotopic and laminar organization of fos-like immunoreactivity in the medullary and upper cervical dorsal horn induced by noxious facial stimulation in the rat, J. Comp. Neurol. 331 (1993) 495-516.
28. Takemura M., Sugimoto T., Shigenaga Y., Difference in central projection of primary afferents innervating facial and intraoral structures in the rat, Exp. Neurol. 111 (1991) 324-331.
29. Anton F., Herdegen T., Peppel P., Leah J.D., c-Fos-like immunoreactivity in rat brainstem neurons following noxious chemical stimulation of the nasal mucosa, Neuroscience 41 (1991) 629-641.
30. McCulloch P.F., Panneton W.M., Fos immunohistochemical determination of brainstem neuronal activation in the muskrat after nasal stimulation, Neuroscience 78 (1997) 913-925.
31. Panneton W.M., Primary afferent projections from the upper respiratory tract in the muskrat, J. Comp. Neurol. 308 (1991) 51-65.
32. Carstens E., Saxe I., Ralph R., Brainstem neurons expressing c-Fos immunoreactivity following irritant chemical stimulation of the rat's tongue, Neuroscience 69 (1995) 939-953.
33. Hathaway C.B., Hu J.W., Bereiter D.A., Distribution of Fos-like immunoreactivity in the caudal brainstem of the rat following noxious chemical stimulation of the temporomandibular joint, J. Comp. Neurol. 356 (1995) 444-456.
34. Strassman A.M., Mineto Y., Vos B.P., Distribution of fos-like immunoreactivity in the medullary and upper cervical dorsal horn produced by stimulation of dural blood vessels in the rat, J. Neurosci. 14 (1994) 3725-3735.
35. Julia V., Buéno L., Tachykinergic mediation of viscerosensitive responses to acute inflammation in rats: Role of CGRP, Am. J. Physiol. (Gastrointest. Liver Physiol.) 272 (1997) G141-G146.
36. Giuliani S., Maggi C.A., Meli A., Capsaicin-sensitive afferents in the rat urinary bladder activate a spinal sympathetic cardiovascular reflex, Naunyn Schmiedebergs Arch. Pharmacol. 338 (1988) 411-416.
37. Boucher M., Meen M., Codron J.P., Coudoré F., Kémény J.L., EsChalier A., Cyclophosphamide cystitis in rats: A new behavioral model of visceral pain, Fond. Clin. Pharmacol. 11 (1997) 160.
38. Hanno P.M., Painful bladder syndromes, in: Hanno P.M., Wein A.J. (Eds.), Clinical Manual of Urology, 2nd Ed., Mc Graw-Hill Inc., Health Professions division, New York, 1994, pp. 205-214.
39. Tokunaga S., Kuru M., Vesico-constrictor center and vesico-relaxer center in the medulla, Proc. Jpn. Acad. 35 (1959) 365-374.
40. Randich A., Maixner W., Interactions between cardiovascular and pain regulatory systems, Neurosci. Biobehav. Rev. 8 (1984) 343-367.
41. Bossut D.F., Maixner W., Effects of cardiac vagal afferent electro- stimulation on the responses of trigeminal and trigeminothalamic neurons to noxious orofacial stimulation, Pain 65 (1996) 101-109.
42. Bernstein I.L., Learned taste aversions in children receiving chemotherapy, Science 200 (1978) 1302-1303.
43. Houpt T.A., Philopena J.M., Wessel T.C., Joh T.H., Smith G.P., Increased c-fos expression in nucleus of the solitary tract correlated with conditioned taste aversion to sucrose in rats, Neurosci. Lett. 172 (1994) 1-5.
44. Jancsó G., Maggi C.A., Distribution of capsaicin-sensitive urinary bladder afferents in the rat spinal cord, Brain Res. 418 (1987) 371-376.